Kyunggi Cho

Songnam, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

The Inflammatory Characteristics of Symptomatic Glioma Associated With Poor Prognosis and Chemoresistance via Tumor Necrosis Factor Signaling Pathway.

The Inflammatory Characteristics of Symptomatic Glioma Associated With Poor Prognosis and Chemoresistance via Tumor Necrosis Factor Signaling Pathway.

Journal: Brain tumor research and treatment
Published: October 01, 2024

Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis.

Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis.

Journal: Journal of neuro-oncology
Published: May 21, 2024

Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker.

Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker.

Journal: Brain tumor research and treatment
Published: March 11, 2023

Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy.

Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: December 22, 2022

Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy.

Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy.

Journal: Cell & bioscience
Published: October 13, 2022

Molecular characteristics of incidental lower-grade glioma for treatment decision-making.

Molecular characteristics of incidental lower-grade glioma for treatment decision-making.

Journal: Journal of neurosurgery
Published: April 26, 2022

Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome.

Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome.

Journal: International journal of molecular sciences
Published: December 29, 2021

NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM.

NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM.

Journal: Cancers
Published: December 20, 2021

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.

Journal: PloS one
Published: July 26, 2020

Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.

Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.

Journal: PloS one
Published: July 13, 2020

Associations of miR‑146aC>G, miR‑149C>T, miR‑196a2C>T and miR‑499A>G polymorphisms with brain tumors.

Associations of miR‑146aC>G, miR‑149C>T, miR‑196a2C>T and miR‑499A>G polymorphisms with brain tumors.

Journal: Oncology reports
Published: January 23, 2018

The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area.

The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area.

Journal: Journal of neuro-oncology
Published: February 24, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026